NEW YORK (Reuters Health) – The German Society for Rheumatology (DGRh) has updated its guidelines to reflect the recent impact of the pandemic, noting among its key changes that anti-rheumatic medication should not be changed solely for fear of SARS-CoV-2…
Read More
Flixonase Allergy & Hayfever 24 Hour
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. FLIXONASE®ALLERGY & HAYFEVER 24 HOUR ALLERGY & HAYFEVER 24 HOUR Fluticasone propionate, 50 mcg per spray Consumer Medicine Information What is in this leaflet? Please read this…
Read More
Celestone M
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CELESTONE® M Betamethasone valerate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Celestone M. It does not contain all the…
Read More
DermAid 1% spray
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. DERMAID 1% Hydrocortisone 1 % w/w CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about DermAid 1% spray. It does not…
Read More
Erbitux
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ERBITUX® cetuximab (rmc) CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about ERBITUX. It does not contain all the available information….
Read More
DermAid 1% solution
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. DERMAID 1% Hydrocortisone 1 % w/w CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about DermAid 1% solution. It does not…
Read More